转移性非小细胞肺癌姑息性放疗的拒绝及其预后意义

The Refusal of Palliative Radiation in Metastatic Non-Small Cell Lung Cancer and Its Prognostic Implications.

作者信息

Stavas Mark J, Arneson Kyle O, Ning Matthew S, Attia Albert A, Phillips Sharon E, Perkins Stephanie M, Shinohara Eric T

机构信息

Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

出版信息

J Pain Symptom Manage. 2015 Jun;49(6):1081-1087.e4. doi: 10.1016/j.jpainsymman.2014.11.298. Epub 2015 Jan 13.

Abstract

CONTEXT

Patients with metastatic non-small cell lung cancer (NSCLC) have limited survival. Population studies have evaluated the impact of radiation refusal in the curative setting; however, no data exist concerning the prognostic impact of radiation refusal in the palliative care setting.

OBJECTIVES

To investigate the patterns of radiation refusal in newly diagnosed patients with metastatic NSCLC.

METHODS

Patients with Stage IV NSCLC diagnosed between 1988 and 2010 were identified in the Surveillance, Epidemiology, and End Results database. Univariate and multivariate analyses were used to identify predictors for refusal of radiation and the impact of radiation and refusal on survival in the palliative setting.

RESULTS

A total of 285,641 patients were initially included in the analysis. Palliative radiation was recommended in 42% and refused by 3.1% of patients. Refusal rates remained consistent across included years of study. On multivariate analysis, older, nonblack/nonwhite, unmarried females were more likely to refuse radiation (P < 0.001 in all cases). Median survival for patients refusing radiation was three months vs. five months for those receiving radiation and two months for those whom radiation was not recommended.

CONCLUSION

Patients with metastatic NSCLC who refuse recommended palliative radiation have a poor survival. Radiation refusal or the recommendation against treatment can serve as a trigger for integrating palliative care services sooner and contributes greatly to prognostic awareness. Further investigation into this survival difference and the factors behind refusal are warranted.

摘要

背景

转移性非小细胞肺癌(NSCLC)患者的生存期有限。人群研究评估了在根治性治疗中拒绝放疗的影响;然而,关于姑息治疗中拒绝放疗的预后影响尚无数据。

目的

调查新诊断的转移性NSCLC患者拒绝放疗的模式。

方法

在监测、流行病学和最终结果数据库中识别出1988年至2010年间诊断为IV期NSCLC的患者。采用单因素和多因素分析来确定拒绝放疗的预测因素以及放疗和拒绝放疗对姑息治疗中生存期的影响。

结果

共有285,641名患者最初纳入分析。42%的患者被建议进行姑息性放疗,其中3.1%的患者拒绝。在纳入研究的各年份中,拒绝率保持一致。多因素分析显示,年龄较大、非黑人/非白人、未婚女性更有可能拒绝放疗(所有情况P<0.001)。拒绝放疗的患者中位生存期为3个月,接受放疗的患者为5个月,未被建议放疗的患者为2个月。

结论

拒绝推荐的姑息性放疗的转移性NSCLC患者生存期较差。拒绝放疗或不建议治疗可促使更早整合姑息治疗服务,并对预后认识有很大帮助。有必要进一步研究这种生存差异及拒绝背后的因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索